Catalog · Regenerative

ARA-290

CAS 1208243-50-8MW 1,258.42 g/mol≥99.0% Purity

An erythropoietin-derived peptide studied for innate-repair-receptor signaling.

Quantity per vial
Vials
1
$84.99
  • Free cold-chain shipping over $200
  • Signed COA included with every vial
  • Batch-pinned ordering for protocol continuity

Research Use Only. Sold for research and identification purposes only. Not intended for human dosing, injection, or ingestion.

Mass-Spec Verified

HPLC + LC-MS per batch at Janoshik.

99% Purity Threshold

Below-spec lots are destroyed, not sold.

Cold-Chain 2–8°C

Continuous transit temperature logging.

U.S. cGMP Compounded

Domestic manufacturing, lot traceability.

Mechanism of action

ARA-290 (cibinetide) is an 11-amino-acid peptide derived from the helix-B region of erythropoietin. It is studied as a selective agonist of the innate repair receptor — a heterocomplex of the EPO receptor and the β-common receptor (CD131) — associated with tissue protection and anti-inflammatory signaling.

Importantly, it is non-erythropoietic, separating tissue-protective signaling from red-blood-cell effects, which makes it a focused research tool.

Full research overview, applications & FAQ →